Zika virus

CDC updates Zika testing and management guidelinesPediatricians need to stay committed to following those infants with possible exposure to Zika to understand the effects of Zika infection and ensure appropriate care and services.
Study: Clinical trials indicate positive results for Zika vaccineThree Phase 1 human clinical trials evaluating the efficacy of an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it to be safe and well tolerated, according to a recent study. Plus: Another study has found an association between postmenopausal vasomotor symptoms (VMS), including hot flashes and night sweats, and elevated risk of diabetes.
New ‘dipstick’ test for Zika, dengueA fast and cost-effective new dipstick test for Zika virus can distinguish between it and dengue viruses without cross-reactivity, according to a report in Science Translational Medicine. Also, results of a new randomized controlled trial—the largest of its kind to date—suggest that text messaging may help some pregnant women quit smoking.
First Zika test for blood donations wins nod from FDA
Zika, HIV coinfection in pregnancy
Zika virus updatesThe CDC sets up a registry to document the disease in pregnancy and infants. Plus: A look at Zika, HIV infection. Also, Zika care standards updated.
Granting Exclusive License for Zika Vaccine Is Causing ConcernThe U.S. Army wants to grant an exclusive license for a Zika vaccine, but there are worries that exclusivity would lead to a high price.
CDC issues advisory on Zika testingThe latest on testing guidelines for Zika from the CDC. Plus: Are corticosteroids effective when administered only hours before delivery? Also, a look at the prevalence of hepatitis C among pregnancy women in the United States.
Zika vaccine progress: Five things to knowTo date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process.
Who is being tested for BRCA?A study looks at who is being tested for BRCA mutations as testing becomes more common. Also, a look at the impact of Zika virus on birth defects using benchmark data. Plus: How is the United States doing with infant mortality?